Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Chemoradiotherapy"" wg kryterium: Temat


Tytuł :
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.
Autorzy :
Boulle G; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France.
Velut Y; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France.
Mansuet-Lupo A; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France; Department of Pathology, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France.
Gibault L; Department of Pathology, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Paris, France.
Blons H; University Paris Descartes, Paris, France; INSERM UMRS 1147, Paris, France; Department of Biochemistry, APHP, Hôpital Européen Georges Pompidou, Paris, France.
Fournel L; University Paris Descartes, Paris, France; Department of Thoracic Surgery, APHP, Hôpital Cochin, Paris, France; INSERM U1124, Paris, France.
Boni A; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France.
Cremer I; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France.
Wislez M; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; Department of Respiratory Medicine, APHP, Hôpital Cochin, Paris, France.
Duchatelle V; Department of Pathology, St Joseph Hospital, Paris, France.
Trédaniel J; University Paris Descartes, Paris, France; INSERM U1124, Paris, France; Department of Oncology, St Joseph Hospital, Paris, France.
Hammond SA; Research and Early Discovery, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
Herbst R; Research and Early Discovery, Oncology Research and Development, AstraZeneca, Gaithersburg, MD, USA.
Alifano M; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France; Department of Thoracic Surgery, APHP, Hôpital Cochin, Paris, France.
Giraud P; University Paris Descartes, Paris, France; APHP, Hôpital Européen Georges Pompidou, Department of Radiotherapy, Paris, France.
Damotte D; Institut National de La Santé et de La Recherche Médicale (INSERM), UMRS 1138, Cordeliers Research Center, Team Cancer, inflammation and complement, Paris, France; University Paris Descartes, Paris, France; University Pierre et Marie Curie-Paris, Paris, France; Department of Pathology, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Cochin, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Aug; Vol. 135, pp. 221-229. Date of Electronic Publication: 2020 Jun 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/mortality
CD8-Positive T-Lymphocytes/*immunology
Carcinoma, Non-Small-Cell Lung/*therapy
Forkhead Transcription Factors/*analysis
Lung Neoplasms/*therapy
Lymphocytes, Tumor-Infiltrating/*immunology
Adult ; Aged ; Aged, 80 and over ; B7-H1 Antigen/analysis ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemoradiotherapy, Adjuvant ; Female ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX.
Autorzy :
Boisselier P; Radiotherapy Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
Kaminsky MC; Radiotherapy Department, Lorraine Cancer Institute, Vandœuvre-Lès-Nancy, France.
Thézenas S; Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
Gallocher O; Radiotherapy Department, Clinique Pasteur, Toulouse, France.
Lavau-Denes S; Clinical Research Unit, Dupuytren University Hospital, Limoges, France.
Garcia-Ramirez M; Radiotherapy Department, Libourne Hospital Center, Libourne, France.
Alfonsi M; Radiotherapy Department, Sainte Catherine Institute, Avignon, France.
Cupissol D; Oncology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
de Forges H; Clinical Research and Innovation Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
Janiszewski C; Clinical Research and Innovation Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
Geoffrois L; Radiotherapy Department, Lorraine Cancer Institute, Vandœuvre-Lès-Nancy, France.
Sire C; Radiotherapy Department, Bretagne Sud Hospital, Lorient, France.
Senesse P; Clinical Nutrition and Gastroenterology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; IRCM, University of Montpellier, Inserm, and ICM, Montpellier, France.
Pokaż więcej
Corporate Authors :
Head and Neck Oncology and Radiotherapy Group (GORTEC)
Źródło :
The American journal of clinical nutrition [Am J Clin Nutr] 2020 Dec 10; Vol. 112 (6), pp. 1523-1531.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Food, Formulated*
Head and Neck Neoplasms/*therapy
Immunologic Factors/*therapeutic use
Adult ; Aged ; Dietary Supplements ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Is there a survival advantage of oral immunonutrition in head and neck cancer?
Autorzy :
Adiamah A; Department of Surgery, Queen's Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, United Kingdom.
Lewis S; Department of Gastroenterology, Derriford Hospital, Plymouth, United Kingdom.
Pokaż więcej
Źródło :
The American journal of clinical nutrition [Am J Clin Nutr] 2020 Dec 10; Vol. 112 (6), pp. 1427-1428.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Head and Neck Neoplasms*
Double-Blind Method ; Food, Formulated ; Humans
Czasopismo naukowe
Tytuł :
Randomised clinical trial on 7-days-a-week postoperative radiotherapy vs. concurrent postoperative radio-chemotherapy in locally advanced cancer of the oral cavity/oropharynx.
Autorzy :
Wozniak G; Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Misiołek M; Department of Laryngology, Silesian Medical University, Katowice, Poland.
Idasiak A; Radiotherapy Clinic and Teaching Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Dębosz-Suwińska I; Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Jaworska M; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Bal W; Department of Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Maciejewski B; Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Miszczyk L; Department of Radiation Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Składowski K; Radiotherapy Clinic and Teaching Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Suwinski R; Radiotherapy Clinic and Teaching Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2020 Dec 01; Vol. 93 (1116), pp. 20200288. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Chemoradiotherapy*
Mouth Neoplasms/*therapy
Oropharyngeal Neoplasms/*therapy
Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Mouth Neoplasms/pathology ; Mouth Neoplasms/radiotherapy ; Mouth Neoplasms/surgery ; Neoplasm Staging ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/radiotherapy ; Oropharyngeal Neoplasms/surgery ; Postoperative Period ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Autorzy :
Crimì F; Department of Medicine-DIMED, Institute of Radiology, University Hospital of Padova, Padua, Italy.
Capelli G; Clinica Chirurgica I, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University Hospital of Padova, Via Nicolò Giustiniani 2, 35128, Padua, Italy.
Spolverato G; Clinica Chirurgica I, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University Hospital of Padova, Via Nicolò Giustiniani 2, 35128, Padua, Italy. .
Bao QR; Clinica Chirurgica I, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University Hospital of Padova, Via Nicolò Giustiniani 2, 35128, Padua, Italy.
Florio A; Department of Medicine-DIMED, Institute of Radiology, University Hospital of Padova, Padua, Italy.
Milite Rossi S; Department of Medicine-DIMED, Institute of Radiology, University Hospital of Padova, Padua, Italy.
Cecchin D; Nuclear Medicine Unit, Department of Medicine-DIMED, University Hospital of Padova, Padua, Italy.
Albertoni L; Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University Hospital of Padova, Padua, Italy.
Campi C; Department of Mathematics 'Tullio Levi-Civita', University of Padova, Padua, Italy.
Pucciarelli S; Clinica Chirurgica I, Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University Hospital of Padova, Via Nicolò Giustiniani 2, 35128, Padua, Italy.
Stramare R; Department of Medicine-DIMED, Institute of Radiology, University Hospital of Padova, Padua, Italy.
Pokaż więcej
Źródło :
La Radiologia medica [Radiol Med] 2020 Dec; Vol. 125 (12), pp. 1216-1224. Date of Electronic Publication: 2020 May 14.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Magnetic Resonance Imaging/*methods
Neoadjuvant Therapy/*methods
Rectal Neoplasms/*diagnostic imaging
Rectal Neoplasms/*therapy
Adult ; Antimetabolites, Antineoplastic/administration & dosage ; Capecitabine/administration & dosage ; Female ; Fluorouracil/administration & dosage ; Humans ; Male ; Middle Aged ; ROC Curve ; Radiotherapy Dosage ; Rectal Neoplasms/pathology ; Rectal Neoplasms/surgery ; Retrospective Studies ; Sensitivity and Specificity ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles.
Autorzy :
Liu N; Cancer Institute of Xuzhou Medical University, Xuzhou, China.
Ji J; Department of Internal Medicine, NO.731 Hospital of CASIC, Beijing, China.
Qiu H; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Shao Z; Department of Interventional Ultrasound, Zhejiang Cancer Hospital, Hangzhou, China.
Wen X; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Chen A; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yao S; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Zhang X; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Yao H; Cancer Institute of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou, China.
Zhang L; Cancer Institute of Xuzhou Medical University, Xuzhou, China.; Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou, China.
Pokaż więcej
Źródło :
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 305-314.
Typ publikacji :
Journal Article; Video-Audio Media
MeSH Terms :
Antineoplastic Agents*/chemistry
Antineoplastic Agents*/pharmacology
Chemoradiotherapy*
Docetaxel*/chemistry
Docetaxel*/pharmacology
Nanoparticles*/chemistry
Nanoparticles*/therapeutic use
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/therapy
DNA Damage ; Humans ; Male ; PC-3 Cells
Czasopismo naukowe
Tytuł :
Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.
Autorzy :
Raman V; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina. Electronic address: .
Jawitz OK; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Voigt SL; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Rhodin KE; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Kim AW; Division of Thoracic Surgery, Department of Surgery, University of Southern California, Los Angeles, California.
Tong BC; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
D'Amico TA; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Harpole DH; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2020 Dec; Vol. 110 (6), pp. 1832-1839. Date of Electronic Publication: 2020 Jul 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Chemoradiotherapy*
Neoadjuvant Therapy*
Adenocarcinoma/*pathology
Adenocarcinoma/*therapy
Esophageal Neoplasms/*pathology
Esophageal Neoplasms/*therapy
Adenocarcinoma/mortality ; Aged ; Esophageal Neoplasms/mortality ; Esophagectomy ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Neoplasm Staging ; Patient Selection ; Practice Patterns, Physicians' ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate
SCR Disease Name :
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł :
Machine Learning-Guided Adjuvant Treatment of Head and Neck Cancer.
Autorzy :
Howard FM; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
Kochanny S; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
Koshy M; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois.; Department of Radiation Oncology, University of Illinois at Chicago.
Spiotto M; Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, Illinois.; Department of Radiation Oncology, University of Illinois at Chicago.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Pearson AT; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2020 Nov 02; Vol. 3 (11), pp. e2025881. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Deep Learning*
Otorhinolaryngologic Surgical Procedures*
Patient Selection*
Radiotherapy, Adjuvant*
Squamous Cell Carcinoma of Head and Neck/*therapy
Aged ; Cohort Studies ; Female ; Humans ; Hypopharyngeal Neoplasms/pathology ; Hypopharyngeal Neoplasms/therapy ; Laryngeal Neoplasms/pathology ; Laryngeal Neoplasms/therapy ; Logistic Models ; Lymph Nodes/pathology ; Machine Learning ; Male ; Mouth Neoplasms/pathology ; Mouth Neoplasms/therapy ; Neoplasm Grading ; Neoplasm Staging ; Neural Networks, Computer ; Oropharyngeal Neoplasms/pathology ; Oropharyngeal Neoplasms/therapy ; Proportional Hazards Models ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/pathology ; Tumor Burden
Czasopismo naukowe
Tytuł :
Preoperative chemoradiotherapy versus surgery alone for advanced low rectal cancer: a large multicenter cohort study in Japan.
Autorzy :
Akagi T; Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita, 879-5593, Japan.
Inomata M; Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita, 879-5593, Japan. .
Fujishima H; Department of Gastroenterological and Pediatric Surgery, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita, 879-5593, Japan.
Fukuda M; Department of Surgery, Kitano Hospital, Kyoto, Japan.
Konishi T; Department of Colorectal Surgery, Cancer Institute Center, Tokyo, Japan.
Tsukamoto S; Department of Colorectal Surgery, National Cancer Center, Tokyo, Japan.
Teraishi F; Department of Surgery, Okayama University, Okayama, Japan.
Ozawa H; Department of Colorectal Surgery, Tochigi Cancer Center, Utsunomiya, Japan.
Tanaka K; Department of Colorectal Surgery, Osaka Medical College, Osaka, Japan.
Hida K; Department of Surgery, Kyoto University, Kyoto, Japan.
Sakai Y; Department of Surgery, Kyoto University, Kyoto, Japan.
Watanabe M; Department of Surgery, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Surgery today [Surg Today] 2020 Nov; Vol. 50 (11), pp. 1507-1514. Date of Electronic Publication: 2020 Jun 10.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Preoperative Care*
Adenocarcinoma/*surgery
Rectal Neoplasms/*surgery
Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Anastomotic Leak/epidemiology ; Cohort Studies ; Combined Modality Therapy ; Female ; Humans ; Incidence ; Japan ; Male ; Middle Aged ; Neoplasm Staging ; Postoperative Complications/epidemiology ; Rectal Neoplasms/pathology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following Chemoradiotherapy.
Autorzy :
Huang WL; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.; Department of Radiation oncology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, R.O.C.
Luo CW; Division of Breast Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, R.O.C.
Chou CL; Division of Colon & Rectal Surgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan, R.O.C.
Yang CC; Department of Radiation Oncology, Chi-Mei Medical Center, Tainan, Taiwan, R.O.C.; Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan, R.O.C.
Chen TJ; Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan, R.O.C.; Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; Department of Optometry, Chung Hwa University of Medical Technology, Tainan, Taiwan, R.O.C.
Li CF; Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan, R.O.C.
Pan MR; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C. .; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan, R.O.C.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Nov; Vol. 40 (11), pp. 6305-6317.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy*
Gene Expression Regulation, Neoplastic*
Rectal Neoplasms/*genetics
Rectal Neoplasms/*therapy
Ubiquitin-Conjugating Enzymes/*genetics
Aged ; Cell Line, Tumor ; Cell Survival/radiation effects ; DNA Damage ; DNA Repair ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Radiation Tolerance/radiation effects ; Radiation, Ionizing ; Rectal Neoplasms/pathology ; Ubiquitin-Conjugating Enzymes/metabolism
Czasopismo naukowe
Tytuł :
Sequencing of Adjuvant Chemoradiation for Advanced Stage Endometrial Cancer: Outcomes and Toxicity Profiles.
Autorzy :
Arden JD; Departments of Radiation Oncology.
Marvin K; Departments of Radiation Oncology.
Nandalur SR; Departments of Radiation Oncology.
Al-Wahab Z; Gynecologic Oncology, Beaumont Health System, Royal Oak, MI.
Field J; Gynecologic Oncology, Beaumont Health System, Royal Oak, MI.
Gadzinski J; Gynecologic Oncology, Beaumont Health System, Royal Oak, MI.
Rakowski JA; Gynecologic Oncology, Beaumont Health System, Royal Oak, MI.
Rosen B; Gynecologic Oncology, Beaumont Health System, Royal Oak, MI.
Jawad MS; Departments of Radiation Oncology.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2020 Nov; Vol. 43 (11), pp. 755-761.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy, Adjuvant/*methods
Endometrial Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Chemoradiotherapy, Adjuvant/adverse effects ; Disease-Free Survival ; Endometrial Neoplasms/mortality ; Female ; Humans ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer.
Autorzy :
Bakke KM; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Meltzer S; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Grøvik E; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Negård A; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Holmedal SH; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Gjesdal KI; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Bjørnerud A; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Ree AH; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Redalen KR; From the Department of Oncology, Akershus University Hospital, Epigen, Akershus Universitetssykehus HF, 1478 Lørenskog, Norway (K.M.B., S.M., K.I.G., A.H.R., K.R.R.); Department of Physics (K.M.B., A.B.) and Institute of Clinical Medicine (A.N., A.H.R.), University of Oslo, Oslo, Norway; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway (E.G., A.B.); Department of Optometry, Radiography and Lighting Design, University of South-Eastern Norway, Drammen, Norway (E.G.); Department of Radiology, Akershus University Hospital, Lørenskog, Norway (A.N., S.H.H.); Sunnmøre MR-Klinikk, Ålesund, Norway (K.I.G.); and Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway (K.R.R.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2020 Nov; Vol. 297 (2), pp. 352-360. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*
Diffusion Magnetic Resonance Imaging/*methods
Rectal Neoplasms/*diagnostic imaging
Rectal Neoplasms/*therapy
Aged ; Blood Flow Velocity ; Contrast Media ; Disease Progression ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Neovascularization, Pathologic ; Prognosis ; Prospective Studies ; Rectal Neoplasms/mortality ; Rectal Neoplasms/pathology ; Sex Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Low-dose radiotherapy (2×2 g) versus low doses and rituximab in the treatment of marginal zone b-cell lymphoma previously untreated.
Autorzy :
Aviles A; Oncology Research Unit, Departament of Hematology, Oncology Hospital, National Medical Center Unit, Instituto Mexicano del Seguro Social, México DF, Mexico. Electronic address: .
Cleto S; Oncology Research Unit, Departament of Hematology, Oncology Hospital, National Medical Center Unit, Instituto Mexicano del Seguro Social, México DF, Mexico.
Pokaż więcej
Źródło :
Leukemia research [Leuk Res] 2020 Nov; Vol. 98, pp. 106443. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article
MeSH Terms :
Chemoradiotherapy*
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/mortality
Lymphoma, B-Cell, Marginal Zone*/pathology
Lymphoma, B-Cell, Marginal Zone*/therapy
Rituximab/*administration & dosage
Aged ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Radiotherapy Dosage ; Survival Rate
Czasopismo naukowe
Tytuł :
Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-matched Study.
Autorzy :
Wong IYH; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Lam KO; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
Zhang RQ; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Chan WWL; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
Wong CLY; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Chan FSY; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Kwong DLW; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China.
Law SYK; Department of Surgery, The University of Hong Kong, Hong Kong, China.
Pokaż więcej
Źródło :
Annals of surgery [Ann Surg] 2020 Nov; Vol. 272 (5), pp. 779-785.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy*
Esophagectomy*
Esophageal Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/therapeutic use ; Cisplatin/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Paclitaxel/therapeutic use ; Propensity Score ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Dosimetric factors related to postoperative pulmonary complications in locally advanced esophageal cancers treated with preoperative chemoradiotherapy: Literature review].
Autorzy :
Dworczak M; Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France. Electronic address: .
Le Deley MC; Centre Oscar-Lambret, département de méthodologie et biostatistiques, 3, rue F.-Combemale, 59020 Lille, France.
Adenis A; Institut du cancer de Montpellier, département d'oncologie médicale, 208, avenue des Apothicaires, 34298 Montpellier, France; Université Montpellier, IRCM, ICM, Inserm, Montpellier, France.
Piessen G; Hôpital Claude-Huriez, service de chirurgie digestive et oncologique, rue M.-Polonowski, 59000 Lille, France.
Lartigau É; Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France; Université de Lille, CRIStAL UMR 9189, Lille, France.
Mirabel X; Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France.
Lacornerie T; Centre Oscar-Lambret, département de physique médicale, 3, rue F.-Combemale, 59020 Lille, France.
Pasquier D; Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France; Université de Lille, CRIStAL UMR 9189, Lille, France.
Pokaż więcej
Transliterated Title :
Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature.
Źródło :
Bulletin du cancer [Bull Cancer] 2020 Oct; Vol. 107 (10), pp. 982-990. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/methods
Esophageal Neoplasms/*therapy
Lung Diseases/*epidemiology
Postoperative Complications/*epidemiology
Esophageal Neoplasms/pathology ; Humans ; Lung Diseases/etiology ; Neoplasm Staging ; Postoperative Complications/etiology ; Preoperative Period ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł :
[Fudan experience of neoadjuvant treatment for rectal cancer].
Autorzy :
Zhang J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Shen LJ
Wan JF
Yang LF
Zhu J
Zhang Z
Pokaż więcej
Źródło :
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2019 Apr 25; Vol. 22 (4), pp. 336-341.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy, Adjuvant*
Neoadjuvant Therapy*
Rectal Neoplasms/*therapy
Chemoradiotherapy ; China ; Humans ; Quality of Life ; Rectal Neoplasms/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?
Autorzy :
Al-Mamgani A; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. .
Navran A; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Walraven I; Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Schreuder WH; Department of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Tesselaar MET; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Klop WMC; Department of Head and Neck Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2019 Feb; Vol. 276 (2), pp. 575-583. Date of Electronic Publication: 2018 Dec 18.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Chemoradiotherapy*
Larynx*
Organ Sparing Treatments*
Hypopharyngeal Neoplasms/*therapy
Laryngeal Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/therapy ; Chemoradiotherapy, Adjuvant ; Female ; Humans ; Hypopharyngeal Neoplasms/mortality ; Hypopharyngeal Neoplasms/pathology ; Laryngeal Neoplasms/mortality ; Laryngeal Neoplasms/pathology ; Laryngectomy ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Concurrent chemoradiotherapy for head neck cancers. Should organs at risk dose constraints be revisited ?]
Autorzy :
Lapeyre M; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France. Electronic address: .
Biau J; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France.
Miroir J; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France.
Moreau J; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France.
Gleyzolle B; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France.
Brun L; Département de radiothérapie, centre Jean-Perrin, 58, rue Montalembert, BP 5026, 63011 Clermont-Ferrand Cedex 1, France.
Racadot S; Département de radiothérapie, centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.
Graff-Cailleaud P; Département de radiothérapie, institut universitaire du cancer de Toulouse, 1, avenue Irene Joliot-Curie, 31100 Toulouse, France.
Pokaż więcej
Transliterated Title :
Chimioradiothérapie concomitante des cancers des voies aérodigestives supérieures. Faut-il revoir les contraintes de dose dans les organes à risque ?
Źródło :
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2020 Oct; Vol. 24 (6-7), pp. 586-593. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Chemoradiotherapy*/adverse effects
Chemoradiotherapy*/methods
Head and Neck Neoplasms/*therapy
Organs at Risk/*radiation effects
Humans ; Radiotherapy Dosage
Czasopismo naukowe
Tytuł :
The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Autorzy :
Sakin A; Department of Medical Oncology, Yuzuncu Yil University Faculty of Medicine, Van, Turkey.
Sahin S; Department of Medical Oncology, University of Health Sciences, Van Training and Research hospital, Van, Turkey.
Sengul Samanci N; Department of Medical Oncology, Cerrahpasa University Faculty of Medicine, Istanbul, Turkey.
Yasar N; Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Demir C; Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Geredeli C; Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Erhan SS; Department of Patology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Akboru MH; Department of Radiation Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Cihan S; Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Oct; Vol. 26 (7), pp. 1611-1620. Date of Electronic Publication: 2020 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Chemoradiotherapy*
Rectal Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Rectal Neoplasms/pathology ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.
Autorzy :
Liu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wen J; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China.
Yang H; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Li Q; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Chen Y; Department of Thoracic Surgery, Cancer Hospital of Shantou University Medical College, Shantou, China.
Zhu C; Department of Thoracic Surgery, Taizhou Hospital, Wenzhou Medical University, Linhai, China.
Fang W; Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Yu Z; Department of Thoracic Surgery, Tianjin Medical University Cancer Hospital, Tianjin, China.
Mao W; Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
Xiang J; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Han Y; Department of Thoracic Surgery, Sichuan Cancer Hospital, Chengdu, China.
Zhao L; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liu H; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Hu Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liu M; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
Fu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address: .
Xi M; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Oct; Vol. 138, pp. 113-121. Date of Electronic Publication: 2020 Aug 30.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemoradiotherapy*
Esophageal Neoplasms/*therapy
Esophageal Squamous Cell Carcinoma/*therapy
Neoplasm Recurrence, Local/*epidemiology
Adult ; Aged ; Esophageal Neoplasms/mortality ; Esophageal Squamous Cell Carcinoma/mortality ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies